A reduction of vaccines coming out of Pfizer’s European facility won’t impact Canada’s supply of the drug, according to Prime Minister Justin Trudeau.
The company announced it is temporarily reducing deliveries of its COVID-19 vaccine to several nations including Canada, as it is upgrading production capacity, allowing it to soon be able to manufacture up to two billion doses a year. “I want to be very clear; this does not impact our goal to have enough vaccines available by September for every Canadian who wants one,” said Prime Minister Trudeau on Friday morning. “It will also not change our second-quarter goals. Canada must still get ready for the ramp-up phase.”
Trudeau points out there are still plenty of doses on order to go around. “This kind of issue is out of our hands. And that’s why we pursued an aggressive procurement strategy in the first place,” he said. “Canada has one of the most diverse vaccine portfolios in the world and we secured the largest number of doses per capita of any country.”
“We have seven bilateral agreements to ensure flexibility when it comes to supply chains,” concluded Trudeau.